Outcomes in systemic lupus erythematous (SLE) patients treated with belimumab in clinical practice settings: results from the observe study in switzerland

被引：0
|
作者：
von Kempis, J. [1 ]
Dutsch, S. [2 ]
Reuschling, N. [1 ]
Villiger, R. [3 ]
Vallelian, F. [4 ]
Schaer, D. J. [4 ]
Mueller, R. B. [1 ]
机构：
[1] Kantonsspital St Gallen, St Gallen, Switzerland
[2] GlaxoSmithKline AG, Munchenbuchsee, Switzerland
[3] Inselspital Bern, Bern, Switzerland
[4] Univ Spital Zurich, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2017年 / 147卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 3
引用
收藏
页码：4S / 4S
页数：1
相关论文
共 50 条
  • [41] Belimumab Reduces the Frequency of Flares in Patients with Refractory SLE: DATA from Clinical Practice Setting
    Doria, Andrea
    Iaccarino, Luca
    Bettio, Silvano
    Frassi, Micol
    Andreoli, Laura
    Reggia, Rossella
    Zen, Margherita
    Nalotto, Linda
    Gatto, Mariele
    Pea, Lara
    Punzi, Leonardo
    Tincani, Angela
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S292 - S293
  • [42] Relationship Between Corticosteroids and Adverse Events in SLE - Data from the Clinical Trial Belimumab in Subjects with Systemic Lupus Erythematosus
    Emamikia, Sharzad
    Gentline, Cidem
    Backheden, Magnus
    Chatzidionysiou, Katerina
    Arnaud, Laurent
    van Vollenhoven, Ronald F.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] Correction: Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study
    Christopher F. Bell
    Jake Chung
    Bernard Rubin
    Rheumatology and Therapy, 2024, 11 (1) : 219 - 219
  • [44] Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry
    Ayano, Masahiro
    Ueda, Naoyasu
    Mishima, Koji
    Ota, Shun-Ichiro
    Kushimoto, Kazuo
    Tanaka, Atsushi
    Kawano, Shotaro
    Nishimura, Naoya
    Kashiwado, Yusuke
    Doi, Goro
    Nakayama, Tsuyoshi
    Fukumoto, Ryo
    Tsuru, Tomomi
    Suzaki, Midori
    Akahoshi, Mitsuteru
    Maekawa, Makiko
    Omoto, Aya
    Tada, Hitoshi
    Akashi, Koichi
    Horiuchi, Takahiko
    Niiro, Hiroaki
    MODERN RHEUMATOLOGY, 2024,
  • [45] Study of pediatric systemic lupus erythematosus (SLE) patients treated longterm with cyclosporine a (CyA)
    Hiramoto, R.
    Matsumoto, S.
    Nishimura, T.
    Eguchi, H.
    Akikusa, B.
    Komori, I.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1527 - 1527
  • [46] DECREASE OF AUTOPHAGY IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS TREATED WITH BELIMUMAB
    Colasanti, T.
    Spinelli, F. R.
    Barbati, C.
    Massaro, L.
    Ceccarelli, F.
    Vomero, M.
    Morello, F.
    Orefice, V.
    Conti, F.
    Valesini, G.
    Alessandri, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 178 - 178
  • [47] Infections Observed in Rituximab Treated Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register
    McCarthy, Eoghan M.
    Sutton, Emily
    Isenberg, David A.
    Rahman, Anisur
    Rhodes, Benjamin
    Hewins, Peter
    McHugh, Neil J.
    Parker, Ben
    Griffiths, Bridget
    Lanyon, Peter
    Vital, Edward M.
    Teh, Lee-Suan
    Akil, Mohammed
    Youssef, Hazem
    D'Cruz, David P.
    Khamashta, Munther
    Erb, Nicola
    Jayne, David
    Edwards, Christopher J.
    Prabu, Athiveer
    Batley, Michael
    Gendi, Nagui
    Dasgupta, Bhaskar
    Stratton, Richard J.
    Yee, Chee-Seng
    Zoma, Asad
    Gordon, Caroline
    Chan, Antoni
    Min, Steven Young
    Dubey, Shirish
    King, Jon
    De Lord, Denise
    O'Riordan, Edmond
    Jeffery, Rachel
    Hassan, Waji
    Regan, Marian
    Bruce, Ian N.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [48] Sleep Disorders in Patients with systemic Lupus erythematosus (SLE) - Results of the LuLa- Study
    Kloubert, I.
    Asfour, M.
    Chehab, G.
    Richter, J.
    Fischer-Betz, R.
    Winkler-Rohlfing, B.
    Willers, R.
    Schneider, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 57 - 57
  • [49] Characterization and Outcomes in Patients Treated With Apremilast in Routine Clinical Practice in Spain: Results From the APPRECIATE Study
    Herranz, P.
    Trasobares, L.
    Mateu, A.
    Martinez, E.
    Ruiz-Villaverde, R.
    Baniandres, O.
    Mataix Diaz, J.
    Jimenez-Gomez, N.
    Serra, M.
    Ruiz Genao, D. P.
    Rivera, N.
    Tercedor-Sanchez, J.
    Garcia, C.
    Cordey, M.
    Herrera-Acosta, E.
    ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (09): : 817 - 827
  • [50] A Novel Biomarker Identifies Systemic Lupus Erythematous (SLE) Patients Who Benefit from Obexelimab (XmAb®5871) Treatment
    Ding, Ying
    Zack, Debra
    Burington, Bart
    Yang, Allen
    Merrill, Joan
    James, Judith
    Desjarlais, John
    Clynes, Raphael
    Guthridge, Joel
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345